ABSTRACT
Objetivo: iinvestigar a potencial associação entre a hipertensão arterial sistêmica (HAS) e a gravidade da COVID-19. Métodos: realizou-se uma pesquisa eletrônica no Medline, Scopus e Web of Science acerca da relação entre HAS e COVID-19. Resultados: as primeiras hipóteses levantadas revelaram que a associação entre as doenças estava no tratamento com inibidores da enzima de conversão da angiotensina e bloqueadores dos receptores da angiotensina. Contudo, em um estudo experimental, observou-se que os pacientes hipertensos tratados com esses medicamentos apresentaram menor taxa de gravidade da doença. Conclusão: até o momento, a relação de HAS e COVID-19 é conflitante.(AU)
Objective: to investigate the potential association between systemic arterial hypertension (SAH) and the severity of COVID-19. Methods: An electronic research on Medline, Scopus and Web of Science was conducted about the relationship between SAH and COVID-19. Results: The first hypotheses raised revealed that the association between the diseases was in the treatment with angiotensin conversion enzyme inhibitors and angiotensin receptor blockers. However, in an experimental study it was observed that hypertensive patients treated with these drugs had a lower rate of disease severity. Conclusion: So far, the relationship between SAH and COVID-19 is conflicting.(AU)